A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911.

Press, Oliver W

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911. [electronic resource] - Blood Sep 2003 - 1606-12 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0006-4971

10.1182/blood-2003-01-0287 doi


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Humans
Iodine Radioisotopes--administration & dosage
Lymphoma, Follicular--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Neural Tube Defects--chemically induced
Patient Compliance
Prednisone--administration & dosage
Remission Induction
Survival Rate
Treatment Outcome
Vincristine--administration & dosage